Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. QQQ
8. LDOS
9. HUM
10. KTOS

Go back to Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

Sangamo Therapeutics (SGMO) Misses Q2 EPS by 2c

August 5, 2021 4:48 PM EDT

Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.33), $0.02 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $27.9 million versus the consensus estimate of $26.48 million.

Cash, cash equivalents and marketable securities as of June 30, 2021 were $578.9 million compared to $692.0 million as of December 31,... More